178 related articles for article (PubMed ID: 25970789)
1. Proteomic profiling of high risk medulloblastoma reveals functional biology.
Staal JA; Lau LS; Zhang H; Ingram WJ; Hallahan AR; Northcott PA; Pfister SM; Wechsler-Reya RJ; Rusert JM; Taylor MD; Cho YJ; Packer RJ; Brown KJ; Rood BR
Oncotarget; 2015 Jun; 6(16):14584-95. PubMed ID: 25970789
[TBL] [Abstract][Full Text] [Related]
2. A Proteogenomic Approach to Understanding MYC Function in Metastatic Medulloblastoma Tumors.
Staal JA; Pei Y; Rood BR
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775567
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis of Medulloblastoma reveals functional biology with translational potential.
Rivero-Hinojosa S; Lau LS; Stampar M; Staal J; Zhang H; Gordish-Dressman H; Northcott PA; Pfister SM; Taylor MD; Brown KJ; Rood BR
Acta Neuropathol Commun; 2018 Jun; 6(1):48. PubMed ID: 29880060
[TBL] [Abstract][Full Text] [Related]
4. Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling.
Forget A; Martignetti L; Puget S; Calzone L; Brabetz S; Picard D; Montagud A; Liva S; Sta A; Dingli F; Arras G; Rivera J; Loew D; Besnard A; Lacombe J; Pagès M; Varlet P; Dufour C; Yu H; Mercier AL; Indersie E; Chivet A; Leboucher S; Sieber L; Beccaria K; Gombert M; Meyer FD; Qin N; Bartl J; Chavez L; Okonechnikov K; Sharma T; Thatikonda V; Bourdeaut F; Pouponnot C; Ramaswamy V; Korshunov A; Borkhardt A; Reifenberger G; Poullet P; Taylor MD; Kool M; Pfister SM; Kawauchi D; Barillot E; Remke M; Ayrault O
Cancer Cell; 2018 Sep; 34(3):379-395.e7. PubMed ID: 30205043
[TBL] [Abstract][Full Text] [Related]
5. DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with In Silico Analysis to Identify Novel Therapeutic Targets.
Hanaford AR; Archer TC; Price A; Kahlert UD; Maciaczyk J; Nikkhah G; Kim JW; Ehrenberger T; Clemons PA; Dančík V; Seashore-Ludlow B; Viswanathan V; Stewart ML; Rees MG; Shamji A; Schreiber S; Fraenkel E; Pomeroy SL; Mesirov JP; Tamayo P; Eberhart CG; Raabe EH
Clin Cancer Res; 2016 Aug; 22(15):3903-14. PubMed ID: 27012813
[TBL] [Abstract][Full Text] [Related]
6. Proteomic profiling of medulloblastoma reveals novel proteins differentially expressed within each molecular subgroup.
Narayan V; Jaiswal J; Sugur H; Sd S; Rao S; Chatterjee A; Gowda H; A A; Somanna S; Santosh V
Clin Neurol Neurosurg; 2020 Sep; 196():106028. PubMed ID: 32580068
[TBL] [Abstract][Full Text] [Related]
7. Silencing of thrombospondin-1 is critical for myc-induced metastatic phenotypes in medulloblastoma.
Zhou L; Picard D; Ra YS; Li M; Northcott PA; Hu Y; Stearns D; Hawkins C; Taylor MD; Rutka J; Der SD; Huang A
Cancer Res; 2010 Oct; 70(20):8199-210. PubMed ID: 20876797
[TBL] [Abstract][Full Text] [Related]
8. Update on the integrated histopathological and genetic classification of medulloblastoma - a practical diagnostic guideline.
Pietsch T; Haberler C
Clin Neuropathol; 2016; 35(6):344-352. PubMed ID: 27781424
[TBL] [Abstract][Full Text] [Related]
9. Medulloblastoma genomics in the modern molecular era.
Kumar R; Liu APY; Northcott PA
Brain Pathol; 2020 May; 30(3):679-690. PubMed ID: 31799776
[TBL] [Abstract][Full Text] [Related]
10. Establishment and characterization of an orthotopic patient-derived Group 3 medulloblastoma model for preclinical drug evaluation.
Sandén E; Dyberg C; Krona C; Gallo-Oller G; Olsen TK; Enríquez Pérez J; Wickström M; Estekizadeh A; Kool M; Visse E; Ekström TJ; Siesjö P; Johnsen JI; Darabi A
Sci Rep; 2017 Apr; 7():46366. PubMed ID: 28417956
[TBL] [Abstract][Full Text] [Related]
11. Large cell/anaplastic medulloblastoma: outcome according to myc status, histopathological, and clinical risk factors.
von Hoff K; Hartmann W; von Bueren AO; Gerber NU; Grotzer MA; Pietsch T; Rutkowski S
Pediatr Blood Cancer; 2010 Mar; 54(3):369-76. PubMed ID: 19908297
[TBL] [Abstract][Full Text] [Related]
12. Expression of FoxM1 is required for the proliferation of medulloblastoma cells and indicates worse survival of patients.
Priller M; Pöschl J; Abrão L; von Bueren AO; Cho YJ; Rutkowski S; Kretzschmar HA; Schüller U
Clin Cancer Res; 2011 Nov; 17(21):6791-801. PubMed ID: 21918172
[TBL] [Abstract][Full Text] [Related]
13. Redefining the molecular substructure of medulloblastoma.
Benmaamar R
Lancet Oncol; 2017 Sep; 18(9):e514. PubMed ID: 28757377
[No Abstract] [Full Text] [Related]
14. Overexpressed TP73 induces apoptosis in medulloblastoma.
Castellino RC; De Bortoli M; Lin LL; Skapura DG; Rajan JA; Adesina AM; Perlaky L; Irwin MS; Kim JY
BMC Cancer; 2007 Jul; 7():127. PubMed ID: 17626635
[TBL] [Abstract][Full Text] [Related]
15. Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma.
Kameda-Smith MM; Zhu H; Luo EC; Suk Y; Xella A; Yee B; Chokshi C; Xing S; Tan F; Fox RG; Adile AA; Bakhshinyan D; Brown K; Gwynne WD; Subapanditha M; Miletic P; Picard D; Burns I; Moffat J; Paruch K; Fleming A; Hope K; Provias JP; Remke M; Lu Y; Reya T; Venugopal C; Reimand J; Wechsler-Reya RJ; Yeo GW; Singh SK
Nat Commun; 2022 Dec; 13(1):7506. PubMed ID: 36473869
[TBL] [Abstract][Full Text] [Related]
16. Proteomics, Post-translational Modifications, and Integrative Analyses Reveal Molecular Heterogeneity within Medulloblastoma Subgroups.
Archer TC; Ehrenberger T; Mundt F; Gold MP; Krug K; Mah CK; Mahoney EL; Daniel CJ; LeNail A; Ramamoorthy D; Mertins P; Mani DR; Zhang H; Gillette MA; Clauser K; Noble M; Tang LC; Pierre-François J; Silterra J; Jensen J; Tamayo P; Korshunov A; Pfister SM; Kool M; Northcott PA; Sears RC; Lipton JO; Carr SA; Mesirov JP; Pomeroy SL; Fraenkel E
Cancer Cell; 2018 Sep; 34(3):396-410.e8. PubMed ID: 30205044
[TBL] [Abstract][Full Text] [Related]
17. Somatic cell transfer of c-Myc and Bcl-2 induces large-cell anaplastic medulloblastomas in mice.
Jenkins NC; Rao G; Eberhart CG; Pedone CA; Dubuc AM; Fults DW
J Neurooncol; 2016 Feb; 126(3):415-24. PubMed ID: 26518543
[TBL] [Abstract][Full Text] [Related]
18. Patched1 deletion increases N-Myc protein stability as a mechanism of medulloblastoma initiation and progression.
Thomas WD; Chen J; Gao YR; Cheung B; Koach J; Sekyere E; Norris MD; Haber M; Ellis T; Wainwright B; Marshall GM
Oncogene; 2009 Apr; 28(13):1605-15. PubMed ID: 19234491
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA profiling in human medulloblastoma.
Ferretti E; De Smaele E; Po A; Di Marcotullio L; Tosi E; Espinola MS; Di Rocco C; Riccardi R; Giangaspero F; Farcomeni A; Nofroni I; Laneve P; Gioia U; Caffarelli E; Bozzoni I; Screpanti I; Gulino A
Int J Cancer; 2009 Feb; 124(3):568-77. PubMed ID: 18973228
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of genomic aberrations during clinical progression of medulloblastoma.
Korshunov A; Benner A; Remke M; Lichter P; von Deimling A; Pfister S
Acta Neuropathol; 2008 Oct; 116(4):383-90. PubMed ID: 18704466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
